1.Preventive strategy for incisional hernia after selective and emergency laparotomy
International Journal of Surgery 2009;36(12):829-831
Incisional hernia is open a major postoperative complication that abdominal surgery remains. The incision type, suture technique, and the choice of primary suture materials are the main factors affecting wound healing. Prophylactic subfascial non-absorbable mesh can be used in high-risk patients to prevent in-cisional hernia.
2.Intermedin and tumor
Journal of International Oncology 2010;37(9):654-657
Intermedin can promote tumor angiogenesis through a variety of signaling pathways. Hypoxia of tumor cells can induce an increased expression of intermedin. Recently, there have been a surge of researches on the relation between intermedin and tumor initiation, progression and metastasis. Intermedin may be a new target for tumor therapy.
3.Correlation between anemia and prognosis of patients with lung cancer
Cancer Research and Clinic 2017;29(7):463-465
Objective To explore the correlation between anemia and the pathogenesis and prognosis of patients with lung cancer. Methods From January 2013 to December 2014, 257 patients with primary lung cancer who were firstly treated at the First Affiliated Hospital of Anhui Medical University were retrospectively analyzed. The clinical data of the patients were collected and the patients were divided into anemia group and control group. The relationship of gender, age, and pathogenesis with anemia was analyzed by x 2 test. Survival analysis was evaluated by Kaplan-Meier and Log-rank test. Results The TNM stage, lymph nodes and remote metastasis , and ECOG score between the two groups were statistically different (x 2 values were 7.94, 4.97, 4.69, 9.02, all P< 0.05). The survival of the two groups showed statistical differences (x2=7.02, P=0.008). Conclusion Anemia might be correlated with the stage, lymph nodes and remote metastasis, ECOG score and prognosis of patients with lung cancer.
4.Research Progress in Ameliorating EGFR-TKIs Acquired Resistance of Targeted Therapy in Lung Cancer by Traditional Chinese Medicine
Chinese Journal of Information on Traditional Chinese Medicine 2016;23(3):126-128,129
Acquired resistance of EGFR-TKIs has become the major limitation of the efficacy of targeted therapy for lung cancer. Lung cancer has been treated by traditional Chinese medicine (TCM) combined with EGFR-TKIs, which originated from clinic. In recent years, reversing research has been conducted based on clinic application to discuss TCM intervening, improving and reversing EGFR-TKIs acquired resistance becoming a novel target for research. This article reviewed mechanism and effects of TCM herbs and compounds’ with the efficacy of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis strengthening the body resistance, and invigorating the circulation of blood, and proposed that the whole regulation and targeted therapy of TCM may carry out synergistic effect and become innovation treatment model for lung cancer.
5.The endothelin system and pulmonary arterial hypertension
Journal of Medical Postgraduates 2003;0(04):-
Endothelin-1 (ET-1) was characterized as a powerful vasoconstrictor and mitogen for smooth muscle. ET-1 binds to two types of receptors: ET_ A-R and ET_ B-R. Pulmonary arterial hypertension (PH) is a severe condition characterized by a progressive increase in pulmonary vascular resistance. The Endothelial dysfunction plays an important role in the development of pulmonary arterial hypertension. PH can be treated by antagonism of ET-1.
6.Function and application of exosomes in malignant tumors
Cancer Research and Clinic 2017;29(1):60-62
Exosome is a sort of vesicle structure attached to cell membrane and released by cells, which contains numerous bioactive molecules, such as proteins, lipids, mRNA, microRNA and DNA fragments. These bioactive molecules are involved in the regulation of many biological processes, not only the participation in the occurrence and development of diverse diseases, but also the close relationship with the invasion and metastasis of tumors. The recent study has indicated that lots of exosomes released from cancer cells participate in a variety of pathological processes as a messenger of cell functions. This article will elaborate the function and application of exosomes in some malignant cancers.
7.Cyclooxygenase-2 selective inhibitors in preventing post-endoscopic retrograde cholangiopancreatog-raphy pancreatitis and hyperamylasemia
Chinese Journal of Digestive Endoscopy 2016;33(7):458-462
Objective To study the effects of cyclooxygenase( COX)?2 selective inhibitors on post?endoscopic retrograde cholangiopancreatography ( ERCP ) pancreatitis ( PEP ) and hyperamylasemia for common bile duct stones. Methods A total of 128 patients with normal serum amylase underwent ERCP from June 2014 to February 2015 in our hospital and were given corresponding drugs to prevent PEP.The pa?tients were divided randomly into four groups:combination group( n=33) , celecoxib group( n=34) , nitro?glycerin group(n=32) and control group(n=29). The serum amylase(AMS), C?reactive protein(CRP) and direct bilirubin( Dbil) after ERCP were measured. Abdominal pain was observed, and the incidence of PEP and post?ERCP hyperamylasemia were recorded. Results The incidence of PEP in combination group, celecoxib group were lower than those in nitroglycerin group and the control group ( 3?03%, 2?94% VS 15?63%, 17?24%),but the difference was not statistically significant(P=0?078).The incidence of post?ERCP hyperamylasemia in combination group and celecoxib group were lower than that in the control group ( 3?03%,5?88% VS 31?03%) with statistically significant difference( P=0?003, P=0?010) . There was no significant difference between nitroglycerin group ( 25%) and control group. The abdominal pain grades of combination group and celecoxib group were lower than those in nitroglycerin group and control group with significant difference(P<0?05). Celecoxib may reduce CRP after ERCP(P=0?001) and nitroglycerin may reduce Dbil after ERCP(P=0?016). Conclusion Celecoxib may reduce the incidence of hyperamylasemia and can help to reduce the abdominal pain and inflammatory reactions after ERCP . Nitroglycerin can help to reduce the Dbil after ERCP .
8."The""Prescriptions""Medication in Treatment of Arthralgia Syndrome"
Journal of Zhejiang Chinese Medical University 2016;40(10):738-740
Objective] Inquire Sun Simiao’s arthralgia syndrome related theory and drug laws in Essential Recipes for Emergent Use, with a view to a more comprehensive understanding of arthralgia to broaden the train of thought, improve the clinical efficacy. [Methods] Read Essential Recipes for Emergent Use book, combined with knowledge of Chinese medicine, to study involved arthralgia syndrome theory and relevant prescriptions and drugs for statistical summary. [Results] Sun Simiao believed arthromyodynia causes included three cold wet gas, kidney, heat etc. The use of medicine in treatment of arthralgia syndrome of wind;pay attention to helping Yang deficiency. Arthromyodynia for different symptoms and disease drug use had their own unique experience. [Conclusion] Sun Simiao’s Essential Recipes for Emergent Use content is rich, extensive and profound, its treatment of Bi syndrome has quite academic value, today, the therapeutic theory for treatment of clinical syndrome has still an important guiding significance.
9.Progress of immunotherapy trials in the treatment of lung cancer
Journal of International Oncology 2015;(3):210-213
Surgery in combination with chemotherapy and radiotherapy is the standard of lung cancer treatment,but postoperative recurrence is very common which usually leads to higher mortality and lower life quality. Immunotherapy on post-operative patients fully mobilizes the body's defense mechanisms,activates the immune cells,and kills residual cancer cells. Current research on lung cancer immunotherapy mainly includes four categories:adoptive immunotherapy,dendritic cell vaccine,non-specific antigen immune therapy and anti-gen-specific vaccine. These studies show lung cancer immunotherapy intervention can effectively reduce postop-erative residual cancer cells,reduce postoperative recurrence rate,prolong survival,significantly improve the prognosis,and is worth spreading in clinical practice.
10.Expression and role of NGX6 in tumor
Journal of International Oncology 2015;(8):605-607
NGX6 is a recently discovered tumor-suppressor gene,which can inhibit tumor invasion and metastasis via suppressing tumor angiogenesis and lymphangiogenesis.The expression of NGX6 gene has nega-tive correlation with many tumors,such as nasopharyngeal carcinoma,lung cancer,colon cancer and so on. Therefore,the measurement of NGX6′s level has a great influence on the prognosis of patients with tumor.